Supplement
Bitter melon
Herbs · Momordica charantia, bitter gourd, balsam pear, karela
Bitter melon is sold as a natural remedy for high blood sugar. The randomized trials on it are numerous but small, and their analyses reach opposing results: from small reductions in HbA1c to no measurable effect compared with placebo. What is certain is that, together with diabetes medication, it can lower blood sugar too much.
What bitter melon is
Bitter melon (Momordica charantia), also called bitter gourd or balsam pear, is a member of the gourd family with a warty, green fruit. In Asia, Africa and South America it is eaten as a vegetable and traditionally used for diabetes. As a food supplement it is available as fruit powder, juice or extract, varying greatly in composition and strength.
In the BK-Score, human evidence stands at 5 out of 10 points. That means there are some controlled studies, but they are small, short and contradict each other. Studied does not mean proven here.
How it works
Which constituents are supposed to influence blood sugar has not been conclusively clarified. A 2003 review describes structural similarities between individual constituents and animal insulin. These pathways come predominantly from laboratory and animal experiments.
No target structure has been confirmed in humans. A 2025 meta-analysis found an improvement in insulin resistance (HOMA-IR) but no effect on the function of the insulin-producing beta cells. Whether a clinical benefit results from this is open.
What is well supported
- A small reduction in blood sugar in some of the analyses. In type 2 diabetes, compared with placebo, fasting glucose fell by 0.72 mmol/l and HbA1c by 0.26 percentage points (10 studies, 1,045 patients) – with low to very low quality of evidence.
- Less insulin resistance. Across 25 randomized trials in prediabetes and type 2 diabetes, fasting glucose, HbA1c, insulin and HOMA-IR fell, with standardized effect sizes between −0.46 and −0.57; beta-cell function remained unchanged.
- Somewhat lower blood lipids. Total cholesterol −9.7 mg/dl and triglycerides −10.2 mg/dl across 8 studies with 423 participants; LDL and HDL did not change significantly.
What the studies show
Peter 2019: small effect, weak studies
Peter and colleagues analysed 10 studies with 1,045 people with type 2 diabetes, lasting 4 to 16 weeks. Compared with placebo, fasting glucose fell by 0.72 mmol/l, post-meal glucose by 1.43 mmol/l and HbA1c by 0.26 percentage points. The authors rate the evidence for the primary endpoints as low to very low, and the risk of bias of the studies as moderate to high.
Laczkó-Zöld 2023: no effect against placebo
This meta-analysis included only randomized trials against placebo: 9 trials with 414 participants over 4 to 16 weeks. Neither fasting glucose (−0.03 mmol/l) nor HbA1c (−0.12 percentage points), blood lipids, weight or blood pressure differed significantly. The authors emphasize the low statistical power and the short duration. Liver and kidney values did not change.
Mkhize 2025: insulin resistance improved
The GRADE-assessed meta-analysis covers 25 studies with 34 sub-analyses in prediabetes and type 2 diabetes. Fasting glucose (SMD −0.46), HbA1c (SMD −0.57), insulin (SMD −0.48) and HOMA-IR (SMD −0.52) fell significantly, beta-cell function (HOMA-β) did not. Standardized effect sizes cannot be translated directly into percentage points of HbA1c.
Where the data stop
- A replacement for diabetes medication. None of the studies tests hard endpoints such as heart attack, kidney damage or mortality; what is measured are surrogate markers over 16 weeks at most. The situation is similar for other substances marketed as blood sugar aids, such as berberine and chromium.
- A consistent effect. Depending on the selection of studies, the result ranges from −0.38 percentage points of HbA1c to no significant effect. An early analysis of 4 trials with 208 participants also found no difference.
- Comparable preparations. Juice, fruit powder and extracts of differing strength were pooled; which preparation does what remains open.
- Weight and blood pressure. The placebo-controlled analysis by Laczkó-Zöld 2023 showed no effect here.
Status, approval and legal
The fruit is sold as a vegetable; powders and extracts are offered as food supplements. No ban on food supplements could be found in Germany; there is no official maximum amount. There is no authorized health claim on blood sugar. The EU Commission has deferred a large number of claims on botanicals – EFSA lists 1,548 such claims. It is not on the 2026 WADA Prohibited List.
Safety
The most important risk follows from the advertised effect itself: a 2003 review describes hypoglycemic coma and seizures in children and possible additive effects with other blood-sugar-lowering agents. An umbrella review of medicinal plants in type 2 diabetes recommends careful monitoring for low blood sugar when diabetes medication is taken at the same time. Anyone taking insulin or other blood-sugar-lowering medication should use bitter melon preparations only after consulting a physician.
Other effects described: a favism-like condition, relevant in glucose-6-phosphate dehydrogenase deficiency, reduced fertility in mice, and headaches. There are no human safety data for pregnancy and breastfeeding. In 2026 a case of herb-induced liver injury after two to three weeks of intake was published, confirmed by a tissue biopsy. In the short studies, liver and kidney values did not change compared with placebo. In the BK-Score, safety data stand at 4 out of 10: little studied, not shown to be dangerous. This text is information and does not replace medical advice.
BK-Score Thin human evidence
| Human evidence | 5 | |
|---|---|---|
| Mechanism | 4 | |
| Safety data | 4 | |
| Hype gap | 3 | |
| Track record of use | 8 |
Evidence 5, because although there are around 25 small randomized trials, their analyses contradict each other: Peter 2019 found HbA1c −0.26 percentage points in type 2 diabetes with low to very low quality of evidence, while Laczkó-Zöld 2023, across 9 placebo-controlled trials with 414 participants, found no significant effect on blood sugar, blood lipids or weight. Mechanism 4, because the pathways – such as insulin-like constituents – have been described mainly in laboratory and animal experiments and no target structure has been confirmed in humans. Safety 4, because the studies lasted 16 weeks at most and the picture otherwise consists of case reports – hypoglycemic coma in children, a favism-like syndrome, a liver injury –; that means little studied, not shown to be dangerous. Hype 3, because bitter melon is marketed as a natural blood sugar remedy while the data are inconsistent and small. Use 8, because the fruit has long been used as a vegetable and home remedy in Asia, Africa and South America; as a concentrated extract it is considerably more recent.
The score rates the state of knowledge, not the substance. “Safety data 4” means this is how well safety has been studied – not how harmless the substance is. “Track record of use 8” means used this long and this widely – that is not proof of efficacy.
Subjective assessment by Biohacking Kompakt based on published scoring rules – not a scientific rating and not a medical recommendation. Rules and all ratings (German)
Frequently asked questions about bitter melon
Does bitter melon lower blood sugar?
Possibly a little; it is not certain. A meta-analysis of 10 studies found a reduction in HbA1c of 0.26 percentage points in type 2 diabetes, with low quality of evidence. An analysis of 9 placebo-controlled trials with 414 participants, by contrast, found no significant effect. The studies are small and lasted 16 weeks at most.
Can bitter melon replace diabetes medication?
There is no evidence for that. No study has examined hard endpoints such as heart attack or kidney damage, and the measured effects on blood sugar values are small and inconsistent. Anyone taking diabetes medication should not swap it for bitter melon on their own.
Is bitter melon dangerous with diabetes medication?
It can enhance the blood-sugar-lowering effect. A review describes possible additive effects with other blood-sugar-lowering agents as well as cases of hypoglycemic coma in children. Anyone taking insulin or tablets for diabetes should consult a physician before taking it and monitor blood sugar closely.
Is bitter melon safe during pregnancy?
Human data on this are lacking. Reduced fertility was observed in mice. Without safety data on pregnancy and breastfeeding, taking it during this time cannot be classified as safe. This applies to concentrated preparations, not to the fruit as an occasional vegetable.
Is bitter melon permitted in Germany?
The fruit is sold as a vegetable; powders and extracts are sold as food supplements. No ban could be found, and there is no official maximum amount. There is no authorized health claim on blood sugar.
Related
- Same goal: Fat burning / weight lossBerberine
- Same goal: Fat burning / weight lossChromium
- Same goal: Fat burning / weight lossForskolin (Coleus forskohlii)
- Similar purposeCitrus bergamot
- Same goal: Fat burning / weight lossBeta-glucan
- Similar purposePentadecanoic acid (C15:0)
Sources
- Peter EL et al., J Ethnopharmacol 2019 – meta-analysis, 10 studies, 1,045 people with type 2 diabetes (PMID 30385422)
- Laczkó-Zöld E et al., Front Nutr 2023 – meta-analysis, 9 placebo-controlled RCTs, 414 participants (PMID 38274207)
- Mkhize SAL et al., Metabolism Open 2025 – GRADE meta-analysis, 25 RCTs, prediabetes and type 2 diabetes (PMID 41280283)
- Zhang X et al., Heliyon 2024 – meta-analysis, 8 RCTs, 423 patients with type 2 diabetes (PMID 38784554)
- Yin RV et al., Nutr Diabetes 2014 – meta-analysis, 4 RCTs, 208 participants (PMID 25504465)
- Amini MR et al., Phytother Res 2024 – meta-analysis on blood lipids, 8 RCTs, 423 participants (PMID 39444254)
- Basch E et al., Am J Health Syst Pharm 2003 – review of efficacy and safety (PMID 12625217)
- Guerra D et al., Cureus 2026 – case report of herb-induced liver injury (PMID 41700226)
- Li E et al., BMC Complement Med Ther 2025 – umbrella review, medicinal plants in type 2 diabetes (PMID 41029669)
- EFSA – health claims under Article 13, including 1,548 deferred claims on botanicals
Open in the database – with search, filters and comparison (German app)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-05.